Healthtech Startups

Opus Genetics is a clinical-stage ophthalmic biopharmaceutical company developing therapies for inherited retinal diseases (IRDs) and other retinal and refractive disorders. It focuses on genetic medicine aimed at preserving and restoring vision for patients with rare eye conditions.

2 investors

Opus Medical provides personalized case management services for injured workers, matching clinical oversight to the severity of each injury. It supports workers and employers through the recovery process using clinical coordination and evidence-based practices, primarily in the workers' compensation context.

2 investors

Ora is an AI-native medical education platform that provides study tools including question banks, flashcards, and content libraries for medical students preparing for licensing exams like the USMLE. The platform serves medical schools and students across the United States, offering institutional partnerships and study resources.

2 investors

Ora Medical supplies medical equipment including the Levity, a device for which they provide funding guidance and reimbursement resources to help patients navigate insurance coverage and alternative financing options.

2 investors

Oral Genome offers a saliva-based, point-of-care testing platform that uses a smartphone app to analyze a test card and identify oral and whole-body health risk indicators within minutes. It is designed for dental, medical, institutional, and individual use across clinical, public-health, and community settings.

2 investors

OraLiva develops an AI-powered, non-invasive oral cancer test designed to detect cancer early during routine dental visits, using single-cell analysis and microfluidic technologies. The company is advancing a point-of-care diagnostic device for dental networks, building on its current lab-developed platform.

2 investors

Orange Grove Bio is a biotech venture firm that builds and backs cell therapy and immuno-oncology companies, forming subsidiary companies (subcos) such as Ipinovyx and DomainOne Therapeutics. It operates in the biopharmaceutical and life sciences investment space.

2 investors

Orbis Education partners educational institutions with healthcare providers to develop and manage online, hybrid, and accelerated degree programs for pre-licensure healthcare professionals. The company addresses healthcare workforce shortages by connecting supply (student graduates) with demand (healthcare employer needs).

2 investors

Orbit is developing a brain-computer interface and accompanying models that decode emotional states. The company's goal is to make emotional context available in human interactions and in the products people use. Its investors include founders and executives from companies such as Google, Apple, Microsoft, Hugging Face, Stability AI, and Dropbox.

2 investors

Orbit Genomics is a precision healthcare company built on OrbiSeq, an AI-enabled genomics platform that analyzes short tandem repeats (STRs) alongside single nucleotide polymorphisms to detect disease biology. Its lead product is a blood test for diagnosing early-stage lung cancer in patients with indeterminate pulmonary nodules, with a pipeline extending across other therapeutic areas.

2 investors

Orbita provides AI-driven patient engagement and communication software that automates workflows across the care journey, including scheduling, intake, procedure prep, and follow-up. It serves healthcare organizations, aiming to increase patient engagement and reduce staff workload.

2 investors

Orchestra BioMed develops medical device products and uses a partnership-based model, collaborating with medical device companies to commercialize them globally. It operates in the medical device and biomedical industry.

2 investors

Orchid Hospital operates two healthcare facilities in Phnom Penh, Cambodia, providing specialized obstetrics, gynecology, pediatrics, maternity care, and general medical services. The hospital combines modern facilities with clinical expertise to serve patients across multiple disciplines including ENT and multi-specialty treatments.

2 investors

Organicin Scientific develops the CinThesis platform for applications in animal health and aquaculture sectors. The company focuses on translating its technology into products for these life science-related markets.

2 investors

Organovo develops regenerative medicine therapies using bioprinting technology to treat serious liver diseases. The company serves the pharmaceutical and biotech sectors with innovative therapeutic approaches based on decades of leadership expertise in life sciences.

2 investors

Origin generates spatial molecular maps from patient tumor samples to enable cancer biology research in native tissue context. The platform combines spatial transcriptomics, imaging, and functional perturbation assays on fresh and archived tumors, paired with AI models for drug response prediction and target discovery.

2 investors

Origin Sciences applies a hologenomic approach integrating host genetics, epigenetics, and microbiome analysis into a single diagnostic framework for deeper health assessment. The company works with leading institutions and technology providers to develop and scale advanced diagnostic assays for clinical and research applications.

2 investors

Orikine Bio develops engineered cytokines called Foldikines™ to reprogram immune responses for treating autoimmune and inflammatory diseases. The platform uses bi-specific cytokines designed to target specific immune cells with precision while minimizing off-target toxicities.

2 investors

OrthoBrain provides AI-powered software and operational tools to enable general dentists to deliver orthodontic care, combining technology guidance and products to support treatment from diagnosis through completion.

2 investors

OrthoFi provides software and services for orthodontic and dental practices, covering patient onboarding, insurance verification and claims processing, patient financing, and accounts receivable collections. Its products, including AcceptCare and OrthoBanc, help practices increase case acceptance, offer flexible payment options to patients, and manage cash flow.

2 investors

Orthoforge provides a diagnostic system using ultrasonic analysis and proprietary algorithms to quantify bone and soft tissue healing after injury, delivered through telemedicine without radiation exposure. The technology targets clinicians and orthopedic patients seeking objective, real-time monitoring of fracture recovery.

2 investors

Orthoscan designs and manufactures mini C-arm imaging devices for use in surgical and clinical environments. The company serves the global medical community with products focused on precision, dose optimization, and image clarity.

2 investors

Oruka is a biopharmaceutical company developing monoclonal antibody therapies aimed at treating plaque psoriasis, psoriatic arthritis, and other dermatologic and inflammatory conditions with fewer annual doses. Its pipeline includes clinical-stage candidates ORKA-001 and ORKA-002 for moderate-to-severe plaque psoriasis.

2 investors

A technology company that develops avatar robots and communication tools to enable people with physical disabilities and mobility constraints to participate in society and work remotely. The company operates in assistive technology and inclusive employment services.

2 investors